Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Pradier

Showing results (91-100 of 110) with videos related to

Pageof 11
Sort By:
Alzheimer'S Research & Therapy|September 14, 2018
Sex ratio in dementia with Lewy bodies balanced between Alzheimer's disease and Parkinson's disease dementia: a cross-sectional studyA Mouton, F Blanc, A Gros, et al.
The Journal of Antimicrobial Chemotherapy|June 4, 2011
Comparative effectiveness of continuing a virologically effective first-line boosted protease inhibitor combination or of switching to a three-drug regimen containing either efavirenz, nevirapine or abacavirT Bommenel, O Launay, J L Meynard, et al.
Journal of Neurovirology|November 6, 2016
A decreasing CD4/CD8 ratio over time and lower CSF-penetrating antiretroviral regimens are associated with a higher risk of neurocognitive deterioration, independently of viral replicationMatteo Vassallo, R Fabre, J Durant, et al.
HIV Medicine|January 30, 2019
Invasive cervical cancer in HIV-infected women: risk and survival relative to those of the general population in France. Results from the French Hospital Database on HIV (FHDH)-Agence Nationale de Recherches sur le SIDA et les Hépatites Virales (ANRS) CO4 cohort studyS Grabar, M Hleyhel, A Belot, et al.
HIV Medicine|January 22, 2011
Rates of cardiovascular disease following smoking cessation in patients with HIV infection: results from the D:A:D study(*)K Petoumenos, S Worm, P Reiss, et al.
Nephron. Clinical Practice|October 6, 2012
Increased time exposure to tenofovir is associated with a greater decrease in estimated glomerular filtration rate in HIV patients with kidney function of less than 60 ml/min/1.73 m2C Fafin, P Pugliese, J Durant, et al.
HIV Medicine|January 22, 2003
Modelling the 3-year risk of myocardial infarction among participants in the Data Collection on Adverse Events of Anti-HIV Drugs (DAD) studyM Law, N Friis-Møller, R Weber, et al.
Gastroenterologie Clinique Et Biologique|August 30, 2000
Non invasive prediction of severe fibrosis in patients with alcoholic liver diseaseA Tran, P Hastier, E M Barjoan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 8, 2008
Changes over time in risk factors for cardiovascular disease and use of lipid-lowering drugs in HIV-infected individuals and impact on myocardial infarction, C A Sabin, A d'Arminio Monforte, et al.
HIV Medicine|May 21, 2014
Increased risk of cardiovascular disease (CVD) with age in HIV-positive men: a comparison of the D:A:D CVD risk equation and general population CVD risk equationsK Petoumenos, P Reiss, L Ryom, et al.
Pageof 11

Showing results (91-100 of 110) with videos related to

Sort By:
Pageof 11
Alzheimer'S Research & Therapy|September 14, 2018
Sex ratio in dementia with Lewy bodies balanced between Alzheimer's disease and Parkinson's disease dementia: a cross-sectional studyA Mouton, F Blanc, A Gros, et al.
The Journal of Antimicrobial Chemotherapy|June 4, 2011
Comparative effectiveness of continuing a virologically effective first-line boosted protease inhibitor combination or of switching to a three-drug regimen containing either efavirenz, nevirapine or abacavirT Bommenel, O Launay, J L Meynard, et al.
Journal of Neurovirology|November 6, 2016
A decreasing CD4/CD8 ratio over time and lower CSF-penetrating antiretroviral regimens are associated with a higher risk of neurocognitive deterioration, independently of viral replicationMatteo Vassallo, R Fabre, J Durant, et al.
HIV Medicine|January 30, 2019
Invasive cervical cancer in HIV-infected women: risk and survival relative to those of the general population in France. Results from the French Hospital Database on HIV (FHDH)-Agence Nationale de Recherches sur le SIDA et les Hépatites Virales (ANRS) CO4 cohort studyS Grabar, M Hleyhel, A Belot, et al.
HIV Medicine|January 22, 2011
Rates of cardiovascular disease following smoking cessation in patients with HIV infection: results from the D:A:D study(*)K Petoumenos, S Worm, P Reiss, et al.
Nephron. Clinical Practice|October 6, 2012
Increased time exposure to tenofovir is associated with a greater decrease in estimated glomerular filtration rate in HIV patients with kidney function of less than 60 ml/min/1.73 m2C Fafin, P Pugliese, J Durant, et al.
HIV Medicine|January 22, 2003
Modelling the 3-year risk of myocardial infarction among participants in the Data Collection on Adverse Events of Anti-HIV Drugs (DAD) studyM Law, N Friis-Møller, R Weber, et al.
Gastroenterologie Clinique Et Biologique|August 30, 2000
Non invasive prediction of severe fibrosis in patients with alcoholic liver diseaseA Tran, P Hastier, E M Barjoan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 8, 2008
Changes over time in risk factors for cardiovascular disease and use of lipid-lowering drugs in HIV-infected individuals and impact on myocardial infarction, C A Sabin, A d'Arminio Monforte, et al.
HIV Medicine|May 21, 2014
Increased risk of cardiovascular disease (CVD) with age in HIV-positive men: a comparison of the D:A:D CVD risk equation and general population CVD risk equationsK Petoumenos, P Reiss, L Ryom, et al.
Pageof 11